Cargando…

RISK OF ADVERSE OUTCOMES IN HOSPITALIZED PATIENTS WITH AUTOIMMUNE DISEASE AND COVID-19: A MATCHED COHORT STUDY FROM NEW YORK CITY

Detalles Bibliográficos
Autores principales: Faye, Adam, Lee, Kate, Laszkowska, Monika, Kim, Judith, Blackett, John, McKenney, Anna, Krigel, Anna, Giles, Jon, Wang, Runsheng, Bernstein, Elana, Green, Peter, Krishnareddy, Suneeta, Hur, Chin, Lebwohl, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862047/
http://dx.doi.org/10.1053/j.gastro.2021.01.156
_version_ 1783647203249618944
author Faye, Adam
Lee, Kate
Laszkowska, Monika
Kim, Judith
Blackett, John
McKenney, Anna
Krigel, Anna
Giles, Jon
Wang, Runsheng
Bernstein, Elana
Green, Peter
Krishnareddy, Suneeta
Hur, Chin
Lebwohl, Benjamin
author_facet Faye, Adam
Lee, Kate
Laszkowska, Monika
Kim, Judith
Blackett, John
McKenney, Anna
Krigel, Anna
Giles, Jon
Wang, Runsheng
Bernstein, Elana
Green, Peter
Krishnareddy, Suneeta
Hur, Chin
Lebwohl, Benjamin
author_sort Faye, Adam
collection PubMed
description
format Online
Article
Text
id pubmed-7862047
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-78620472021-02-05 RISK OF ADVERSE OUTCOMES IN HOSPITALIZED PATIENTS WITH AUTOIMMUNE DISEASE AND COVID-19: A MATCHED COHORT STUDY FROM NEW YORK CITY Faye, Adam Lee, Kate Laszkowska, Monika Kim, Judith Blackett, John McKenney, Anna Krigel, Anna Giles, Jon Wang, Runsheng Bernstein, Elana Green, Peter Krishnareddy, Suneeta Hur, Chin Lebwohl, Benjamin Gastroenterology Natural History and Outcomes Published by Elsevier Inc. 2021-02 2021-02-05 /pmc/articles/PMC7862047/ http://dx.doi.org/10.1053/j.gastro.2021.01.156 Text en Copyright © 2021 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Natural History and Outcomes
Faye, Adam
Lee, Kate
Laszkowska, Monika
Kim, Judith
Blackett, John
McKenney, Anna
Krigel, Anna
Giles, Jon
Wang, Runsheng
Bernstein, Elana
Green, Peter
Krishnareddy, Suneeta
Hur, Chin
Lebwohl, Benjamin
RISK OF ADVERSE OUTCOMES IN HOSPITALIZED PATIENTS WITH AUTOIMMUNE DISEASE AND COVID-19: A MATCHED COHORT STUDY FROM NEW YORK CITY
title RISK OF ADVERSE OUTCOMES IN HOSPITALIZED PATIENTS WITH AUTOIMMUNE DISEASE AND COVID-19: A MATCHED COHORT STUDY FROM NEW YORK CITY
title_full RISK OF ADVERSE OUTCOMES IN HOSPITALIZED PATIENTS WITH AUTOIMMUNE DISEASE AND COVID-19: A MATCHED COHORT STUDY FROM NEW YORK CITY
title_fullStr RISK OF ADVERSE OUTCOMES IN HOSPITALIZED PATIENTS WITH AUTOIMMUNE DISEASE AND COVID-19: A MATCHED COHORT STUDY FROM NEW YORK CITY
title_full_unstemmed RISK OF ADVERSE OUTCOMES IN HOSPITALIZED PATIENTS WITH AUTOIMMUNE DISEASE AND COVID-19: A MATCHED COHORT STUDY FROM NEW YORK CITY
title_short RISK OF ADVERSE OUTCOMES IN HOSPITALIZED PATIENTS WITH AUTOIMMUNE DISEASE AND COVID-19: A MATCHED COHORT STUDY FROM NEW YORK CITY
title_sort risk of adverse outcomes in hospitalized patients with autoimmune disease and covid-19: a matched cohort study from new york city
topic Natural History and Outcomes
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862047/
http://dx.doi.org/10.1053/j.gastro.2021.01.156
work_keys_str_mv AT fayeadam riskofadverseoutcomesinhospitalizedpatientswithautoimmunediseaseandcovid19amatchedcohortstudyfromnewyorkcity
AT leekate riskofadverseoutcomesinhospitalizedpatientswithautoimmunediseaseandcovid19amatchedcohortstudyfromnewyorkcity
AT laszkowskamonika riskofadverseoutcomesinhospitalizedpatientswithautoimmunediseaseandcovid19amatchedcohortstudyfromnewyorkcity
AT kimjudith riskofadverseoutcomesinhospitalizedpatientswithautoimmunediseaseandcovid19amatchedcohortstudyfromnewyorkcity
AT blackettjohn riskofadverseoutcomesinhospitalizedpatientswithautoimmunediseaseandcovid19amatchedcohortstudyfromnewyorkcity
AT mckenneyanna riskofadverseoutcomesinhospitalizedpatientswithautoimmunediseaseandcovid19amatchedcohortstudyfromnewyorkcity
AT krigelanna riskofadverseoutcomesinhospitalizedpatientswithautoimmunediseaseandcovid19amatchedcohortstudyfromnewyorkcity
AT gilesjon riskofadverseoutcomesinhospitalizedpatientswithautoimmunediseaseandcovid19amatchedcohortstudyfromnewyorkcity
AT wangrunsheng riskofadverseoutcomesinhospitalizedpatientswithautoimmunediseaseandcovid19amatchedcohortstudyfromnewyorkcity
AT bernsteinelana riskofadverseoutcomesinhospitalizedpatientswithautoimmunediseaseandcovid19amatchedcohortstudyfromnewyorkcity
AT greenpeter riskofadverseoutcomesinhospitalizedpatientswithautoimmunediseaseandcovid19amatchedcohortstudyfromnewyorkcity
AT krishnareddysuneeta riskofadverseoutcomesinhospitalizedpatientswithautoimmunediseaseandcovid19amatchedcohortstudyfromnewyorkcity
AT hurchin riskofadverseoutcomesinhospitalizedpatientswithautoimmunediseaseandcovid19amatchedcohortstudyfromnewyorkcity
AT lebwohlbenjamin riskofadverseoutcomesinhospitalizedpatientswithautoimmunediseaseandcovid19amatchedcohortstudyfromnewyorkcity